Organon & Co. logo

Organon & Co. (OGN)

Market Closed
22 Jul, 20:00
NYSE NYSE
$
13. 52
+0.01
+0.074%
$
3.55B Market Cap
5.74 P/E Ratio
0.08% Div Yield
1.97M Volume
4.1 Eps
$ 13.51
Previous Close
Add Transaction
Day Range
13.52 13.54
Year Range
5.69 13.6
Want to track OGN and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Product Demand Likely to Aid Organon's (OGN) Q2 Earnings

Product Demand Likely to Aid Organon's (OGN) Q2 Earnings

Continued solid uptake of Organon's (OGN) products is expected to have driven second-quarter revenues.

Zacks | 1 year ago
Seeking Clues to Organon (OGN) Q2 Earnings? A Peek Into Wall Street Projections for Key Metrics

Seeking Clues to Organon (OGN) Q2 Earnings? A Peek Into Wall Street Projections for Key Metrics

Besides Wall Street's top -and-bottom-line estimates for Organon (OGN), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended June 2024.

Zacks | 1 year ago
Organon (OGN) Stock Falls Amid Market Uptick: What Investors Need to Know

Organon (OGN) Stock Falls Amid Market Uptick: What Investors Need to Know

In the latest trading session, Organon (OGN) closed at $21.86, marking a -1.84% move from the previous day.

Zacks | 1 year ago
Earnings Preview: Organon (OGN) Q2 Earnings Expected to Decline

Earnings Preview: Organon (OGN) Q2 Earnings Expected to Decline

Organon (OGN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks | 1 year ago
Organon: Upcoming Q2 Earnings Can Sustain Upward Momentum

Organon: Upcoming Q2 Earnings Can Sustain Upward Momentum

Organon stock experienced significant downside pressure in 2023, however positive Q423 and Q124 earnings have led to a bull run. Organon's business includes women's health, biosimilars, and established brands divisions. The company was spun out of Merck & Co in 2020, and saddled with >$8bn debt. I anticipate Organon's upcoming Q2 2024 earnings will underline growth potential, with a focus on global sales, new product performance, and solid debt management.

Seekingalpha | 1 year ago
Organon (OGN) Upgraded to Strong Buy: What Does It Mean for the Stock?

Organon (OGN) Upgraded to Strong Buy: What Does It Mean for the Stock?

Organon (OGN) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Zacks | 1 year ago
Organon & Co. (OGN) is Attracting Investor Attention: Here is What You Should Know

Organon & Co. (OGN) is Attracting Investor Attention: Here is What You Should Know

Recently, Zacks.com users have been paying close attention to Organon (OGN). This makes it worthwhile to examine what the stock has in store.

Zacks | 1 year ago
Organon (OGN) Increases Yet Falls Behind Market: What Investors Need to Know

Organon (OGN) Increases Yet Falls Behind Market: What Investors Need to Know

In the closing of the recent trading day, Organon (OGN) stood at $20.81, denoting a +0.39% change from the preceding trading day.

Zacks | 2 years ago
Organon (OGN) Stock Drops Despite Market Gains: Important Facts to Note

Organon (OGN) Stock Drops Despite Market Gains: Important Facts to Note

In the most recent trading session, Organon (OGN) closed at $19.93, indicating a -1.04% shift from the previous trading day.

Zacks | 2 years ago
Organon (OGN) Stock Sinks As Market Gains: Here's Why

Organon (OGN) Stock Sinks As Market Gains: Here's Why

In the most recent trading session, Organon (OGN) closed at $20.63, indicating a -0.77% shift from the previous trading day.

Zacks | 2 years ago
Organon & Co. (OGN) is Attracting Investor Attention: Here is What You Should Know

Organon & Co. (OGN) is Attracting Investor Attention: Here is What You Should Know

Zacks.com users have recently been watching Organon (OGN) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.

Zacks | 2 years ago
Organon (OGN) Advances While Market Declines: Some Information for Investors

Organon (OGN) Advances While Market Declines: Some Information for Investors

Organon (OGN) closed the most recent trading day at $20.45, moving +0.49% from the previous trading session.

Zacks | 2 years ago
Loading...
Load More